Nuvilex: A Biotech Methodically Pursuing Cannabis Treatments for Cancer NEW YORK, NY--(Marketwired - May 13, 2014) - Nuvilex, Inc. (OTCQB: NVLX) announced last week that it signed an agreement with the University of Northern Colorado to perform initial studies in the...

Congressional Legislators Agree With Nuvilex's Dr. Mark Rabe on Reclassifying Marijuana NEW YORK, NY--(Marketwired - Feb 14, 2014) - Nuvilex, Inc.'s (OTCQB: NVLX) Dr. Mark L. Rabe has something in common with 18 members of Congress. All of them want marijuana reclassified from its...

Nuvilex's Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced,...

Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary's Scientific Advisory Board NEW YORK, NY--(Marketwired - Dec 23, 2013) - Nuvilex, Inc. (OTCQB: NVLX) upped the ante this month in the field of medical marijuana when it appointed Dr. Mark L. Rabe as Chairman of its...